GlassScriptPhysician profile
Wendy Butler
NPI 1215584180
$2,961.33
in general payments reported to CMS, 2019-2025
18 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $1,005 · 2023: $507 · 2024: $492 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,328.51 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.85 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $191.43 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $178.81 | 2022-2024 | Spravato |
| Supernus Pharmaceuticals, INC. | $162.53 | 2021-2022 | |
| Tris Pharma INC | $140.59 | 2022-2024 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $125.00 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $115.37 | 2024 | Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $95.02 | 2021-2022 | |
| Corium, LLC | $89.69 | 2022 | |
| Alkermes, INC. | $73.26 | 2021-2022 | |
| Neos Therapeutics, LP | $52.12 | 2022 | |
| Lundbeck LLC | $50.27 | 2022 | |
| Sunovion Pharmaceuticals INC. | $46.50 | 2022 | |
| Ironshore Pharmaceuticals INC. | $40.39 | 2022-2023 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $21.53 | 2021 | |
| Adlon Therapeutics L.P. | $19.23 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.